Glial and Vascular Cell Regulation of the Blood-Brain Barrier in Diabetes
- PMID: 35299293
- PMCID: PMC8987684
- DOI: 10.4093/dmj.2021.0146
Glial and Vascular Cell Regulation of the Blood-Brain Barrier in Diabetes
Abstract
As a structural barrier, the blood-brain barrier (BBB) is located at the interface between the brain parenchyma and blood, and modulates communication between the brain and blood microenvironment to maintain homeostasis. The BBB is composed of endothelial cells, basement membrane, pericytes, and astrocytic end feet. BBB impairment is a distinguishing and pathogenic factor in diabetic encephalopathy. Diabetes causes leakage of the BBB through downregulation of tight junction proteins, resulting in impaired functioning of endothelial cells, pericytes, astrocytes, microglia, nerve/glial antigen 2-glia, and oligodendrocytes. However, the temporal regulation, mechanisms of molecular and signaling pathways, and consequences of BBB impairment in diabetes are not well understood. Consequently, the efficacy of therapies diabetes _targeting BBB leakage still lags behind the requirements. This review summarizes the recent research on the effects of diabetes on BBB composition and the potential roles of glial and vascular cells as therapeutic _targets for BBB disruption in diabetic encephalopathy.
Keywords: Astrocytes; Blood-brain barrier; Diabetes mellitus; Endothelial cells; Microglia; Oligodendrocyte precursor cells; Oligodendroglia.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.J Vis Exp. 2019 Mar 26;(145). doi: 10.3791/59249. J Vis Exp. 2019. PMID: 30985749
-
Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier.J Neurochem. 2017 Mar;140(5):741-754. doi: 10.1111/jnc.13747. Epub 2016 Sep 8. J Neurochem. 2017. PMID: 27456748
-
Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit.Toxicol Pathol. 2011 Jan;39(1):172-85. doi: 10.1177/0192623310385830. Epub 2010 Dec 28. Toxicol Pathol. 2011. PMID: 21189317
-
Glial influence on the blood brain barrier.Glia. 2013 Dec;61(12):1939-58. doi: 10.1002/glia.22575. Epub 2013 Oct 7. Glia. 2013. PMID: 24123158 Free PMC article. Review.
-
Crosstalk Among Glial Cells in the Blood-Brain Barrier Injury After Ischemic Stroke.Mol Neurobiol. 2024 Sep;61(9):6161-6174. doi: 10.1007/s12035-024-03939-6. Epub 2024 Jan 27. Mol Neurobiol. 2024. PMID: 38279077 Review.
Cited by
-
Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axis.Endocrine. 2024 Apr;84(1):1-15. doi: 10.1007/s12020-023-03640-z. Epub 2024 Jan 16. Endocrine. 2024. PMID: 38227168 Review.
-
Transcranial photobiomodulation improves insulin therapy in diabetic microglial reactivity and the brain drainage system.Commun Biol. 2023 Dec 8;6(1):1239. doi: 10.1038/s42003-023-05630-3. Commun Biol. 2023. PMID: 38066234 Free PMC article.
-
Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: A narrative review.World J Diabetes. 2023 Jul 15;14(7):1013-1026. doi: 10.4239/wjd.v14.i7.1013. World J Diabetes. 2023. PMID: 37547580 Free PMC article. Review.
-
Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves.Cardiovasc Diabetol. 2023 Nov 15;22(1):314. doi: 10.1186/s12933-023-02056-3. Cardiovasc Diabetol. 2023. PMID: 37968679 Free PMC article. Review.
-
Hyperglycemia in a NOD Mice Model of Type-I Diabetes Aggravates Collagenase-Induced Intracerebral Hemorrhagic Injury.Biomedicines. 2024 Aug 15;12(8):1867. doi: 10.3390/biomedicines12081867. Biomedicines. 2024. PMID: 39200331 Free PMC article.
References
-
- Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ J. 2011;75:1042–8. - PubMed
-
- Sharma B, Singh N. Pitavastatin and 4’-hydroxy-3’-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. Curr Neurovasc Res. 2010;7:180–91. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials